|
AC676 Clinical Trials
1 actively recruiting trial across 1 location
Denver, Colorado1 trial
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Colorado Blood Cancer Institute
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.